CONTENTS:
- Recreational N2O use: just laughing or really bad news? [Editorial]. van Amsterdam J., Brunt T.M., Nabben T., van den Brink W., p. 268-269.
- Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis. Murphy C.E. IV, Wang R.C., Montoy J.C., Whittaker E., Raven M., p. 271-281.
- Commentary on Murphy et al.: What will it take to prescribe extended-release naltrexone to treat alcohol use disorder? Springer S.A., p. 282-283.
- Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Wilson J., Mills K., Freeman T.P., Sunderland M., Visontay R., Marel C., p. 284-298.
- Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta-regression analysis. Bricca A., Swithenbank Z., Scott N., Treweek S., Johnston M., Black N., et al., p. 299-311.
- Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population-based study. Di Castelnuovo A., Costanzo S., Bonaccio M., McElduff P., Linneberg A., Salomaa V., et al., p. 312-325.
- Commentary on Di Castelnuovo et al.: The internal and external validity of cohort studies that measure J-shaped curves for all-cause mortality. Shield K.D., Rehm J., p. 326-327.
- Commentary on Di Castelnuovo et al: Implications of using low volume drinkers instead of never drinkers as the reference group. Naimi T., Chikritzhs T., Stockwell T., p. 327-329.
- Response to commentaries: Alcohol intake and total mortality, strengths and limitations of observational studies, waiting for clinical trials. Di Castelnuovo A., Costanzo S., de Gaetano G., Iacoviello L., p. 329-330.
- Changes in drinking days among United States adults during the COVID-19 pandemic. Nordeck C.D., Riehm K.E., Smail E.J., Holingue C., Kane J.C., Johnson R.M., et al., p. 331-340.
- Commentary on Nordeck et al.: Disruption of social roles and daily routines in the initial phase of the COVID-19 pandemic may explain changes in alcohol use frequency. Chartier K.G., Karriker-Jaffe K.J., p. 341-342.
- Longitudinal prediction of periconception alcohol use: a 20-year prospective cohort study across adolescence, young adulthood and pregnancy. Hutchinson D., Spry E.A., Mohamad Husin H., Middleton M., Hearps S., Moreno-Betancur M., et al., p. 343-353.
- Does receiving an eating disorder diagnosis increase the risk of a subsequent alcohol use disorder? A Danish nationwide register-based cohort study. Mellentin A.I., Skot L., Guala M.M., Stoving R.K., Ascone L., Stenager E., et al., p. 354-367.
- Association of alcohol use disorder on alcohol-related cancers, diabetes, ischemic heart disease and death: a population-based, matched cohort study. Leong C., Bolton J.M., Ekuma O., Prior H.J., Singal D., Nepon J., et al., p. 368-381.
- Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings. Dunlop A.J., White B., Roberts J., Cretikos M., Attalla D., Ling R., et al., p. 382-391.
- Risky decision-making as an antecedent or consequence of adolescent cannabis use: findings from a 2-year longitudinal study. Pacheco-Colon I., Lopez-Quintero C., Coxe S., Limia J.M., Pulido W., Granja K., et al., p. 392-410.
- An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis. Mafirakureva N., Stone J., Fraser H., Nzomukunda Y., Maina A., Thiong'o A.W., et al., p. 411-424.
- Prenatal cannabis use disorders and offspring primary and secondary educational outcomes. Betts K.S., Kisely S., Alati R., p. 425-432.
- Jail and overdose: assessing the community impact of incarceration on overdose. Victor G., Zettner C., Huynh P., Ray B., Sightes E., p. 433-441.
- Commentary on Victor et al. : Preventing overdose deaths following release from incarceration-context is crucial. Borschmann R., Kinner S.A., p. 442-443.
- Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial. Wu L.T., John W.S., Morse E.D., Adkins S., Pippin J., Brooner R.K., et al., p. 444-456.
- Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions. Qeadan F., Madden E.F., p. 457-471.
- Addicted to smoking or addicted to nicotine? A focus group study on perceptions of nicotine and addiction among US adult current smokers, former smokers, non-smokers and dual users of cigarettes and e-cigarettes. Loud E.E., Duong H.T., Henderson K.C., Reynolds R.M., Ashley D.L., Thrasher J.F., et al., p. 472-481.
- Commentary on Loud et al.: Reconsidering nicotine dependence in adults. Notley C., p. 482-483.
- Adolescent electronic cigarette use and tobacco smoking in the Millennium Cohort Study. Staff J., Kelly B.C., Maggs J.L., Vuolo M., p. 484-494.
- Opioid use disorder and the brain: a clinical perspective. Herlinger K., Lingford-Hughes A., p. 495-505.
- The Natural History of Alcoholism: Causes, Patterns, and Paths to Recovery - the virtues of an interdisciplinary perspective of alcoholism and alcoholism recovery [Addiction Classics]. Freed C.R., p. 506-509.